Alterations in γ-actin and tubulin-targeted drug resistance in childhood leukemia

- Verrills, Nicole M., Po'uha, Sela T., Liu, Marjorie L. M., Liaw, Tracy Y. E., Larsen, Martin R., Ivery, Michael T., Marshall, Glenn M., Gunning, Peter W., Kavallaris, Maria

Mast cell function: regulation of degranulation by serine/threonine phosphatases

- Sim, Alistair T. R., Ludowyke, Russell I., Verrills, Nicole M.

Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia: an in vivo study

- Verrills, Nicole M., Liem, Natalia L., Liaw, Tracey Y. E., Hood, Brian D., Lock, Richard B., Kavallaris, Maria

Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT⁺ cancers

- Roberts, Kathryn G., Smith, Amanda M., Sim, Alistair T. R., Ashman, Leonie K., Verrills, Nicole M., McDougall, Fiona, Carpenter, Helen, Horan, Martin, Neviani, Paolo, Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Perrotti, Danilo

Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation

- Kranias, Gregory, Watt, Lauren F., Carpenter, Helen, Holst, Jeff, Ludowyke, Russell, Strack, Stefan, Sim, Alistair T. R., Verrills, Nicole M.

Regulation of CaMKII by phospho-Thr253 or phospho-Thr286 sensitive targeting alters cellular function

- Skelding, Kathryn A., Suzuki, Tatsuo, Gordon, Sarah, Xue, Jing, Verrills, Nicole M., Dickson, Phillip W., Rostas, John A. P.

Controlling the cell cycle: the role of calcium/calmodulin-stimulated protein kinases I and II

- Skelding, Kathryn A., Rostas, John A. P., Verrills, Nicole M.

Essential role of protein phosphatase 2A in metaphase II arrest and activation of mouse eggs shown by okadaic acid, dominant negative protein phosphatase 2A, and FTY720

- Chang, Heng-Yu, Jennings, Phoebe C., Stewart, Jessica, Verrills, Nicole M., Jones, Keith T.

Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease

- Verrills, Nicole M., Irwin, Jennifer A., He, Xiao Yan, Wood, Lisa G., Powell, Heather, Simpson, Jodie L., McDonald, Vanessa M., Sim, Alistair, Gibson, Peter G.

Ser/thr phosphatases: the new frontier for myeloid leukemia therapy?

- Smith, Amanda M., Roberts, Kathryn G., Verrills, Nicole M.

PP2A phosphatase suppresses function of the mesenchymal invasion regulator NEDD9

- Bradbury, Peta, Mahmassani, Maha, Zhong, Jessie, Turner, Kylie, Paul, Andre, Verrills, Nicole M., O'Neill, Geraldine M.

Activity-associated miRNA are packaged in Map1b-enriched exosomes released from depolarized neurons

- Goldie, Belinda J., Dun, Matthew D., Lin, Minjie, Smith, Nathan D., Verrills, Nicole M., Dayas, Christopher V., Cairns, Murray J.

Dephosphorylation of CaMKII at T253 controls the metaphase-anaphase transition

- Hoffman, Alexander, Carpenter, Helen, Kahl, Richard, Watt, Lauren F., Dickson, Phillip W., Rostas, John A. P., Verrills, Nicole M., Skelding, Kathryn A.

Basal protein phosphatase 2A activity restrains cytokine expression: role for MAPKs and tristetraprolin

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Involvement of vacuolar H⁺₋ATPase in killing of human melanoma cells by the sphingosine kinase analogue FTY720

- Tay, Kwang Hong, Liu, Xiaoying, Chi, Mengna, Jin, Lei, Jiang, Chen Chen, Guo, Su Tang, Verrills, Nicole M., Tseng, Hsin-Yi, Zhang, Xu Dong

A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia

- Enjeti, Anoop K., D'Crus, Angel, Melville, Kathleen, Verrills, Nicole M., Rowlings, Philip

Activating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hansbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

- Smith, Amanda M., Dun, Matthew D., Toop, Hamish, Lock, Richard B., Powell, Jason A., Thomas, Daniel, Guthridge, Mark A., Moore, Andrew, Ashman, Leonie K., Skelding, Kathryn A., Enjeti, Anoop, Verrills, Nicole M., Lee, Erwin M., Harrison, Celeste, Kahl, Richard, Flanagan, Hayley, Panicker, Nikita, Mashkani, Baratali, Don, Anthony S., Morris, Jonathan

Activiating protein phosphatase 2A (PP2A) enhances tristetraprolin (TTP) anti-inflammatory function in A549 lung epithelial cells

- Rahman, Md. Mostafizur, Rumzhum, Nowshin N., Hasbro, Philip M., Morris, Jonathan C., Clark, Andrew R., Verrills, Nicole M., Ammit, Alaina J.

Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia

- Toop, Hamish D., Dun, Matthew D., Ross, Bryony K., Flanagan, Hayley M., Verrills, Nicole M., Morris, Jonathan C.